A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)

Study ID
NCT01891344

Study type
Interventional

Study phase
Phase 2

Study status
Completed

Trial Acronym

ARIEL2

Trial Summary

The purpose of this study is to determine which patients with ovarian, fallopian tube, and primary peritoneal cancer will best respond to treatment with rucaparib.

More informations

Trial Starting Date

Oct 30,2013

Requirements

Gender Female
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

491